Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

NICE approves MabThera for leukaemia

July 22, 2009 Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …
News

Phase Forward buys Covance unit for $10m

July 21, 2009 Research and Development CRO, Phase Forward

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …
News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009 Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
News

Jubilant makes solid start to fiscal 2010

July 20, 2009 Manufacturing and Production, Research and Development Jubilant

Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …
News

Drug repositioning a ‘key strategy’ for pharma

July 17, 2009 Research and Development Datamonitor, strategy

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …
News

Merck signs anticoagulant collaboration

July 17, 2009 Research and Development, Sales and Marketing Merck, cv

Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …
News

Effient approved in US

July 17, 2009 Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
News

NICE bypassed in radical innovation boost

July 16, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
News

Oxford BioMedica encouraged by phase I/II Parkinson’s trial

July 15, 2009 Research and Development Oxford BioMedica, Prosavin

News

Poor antigen yields limiting H1N1 vaccine supplies, says WHO

July 15, 2009 Manufacturing and Production, Research and Development h1n1, vaccines

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …
News

Blueprint to fast track innovative drugs and devices

July 14, 2009 Research and Development, Sales and Marketing ABPI, Blueprint, NHS

A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
News

Charles River restructures as president sets retirement date

July 14, 2009 Research and Development CRO, Charles River

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …
News

Clinical trials market worth $50bn in 2008

July 14, 2009 Research and Development CRO, strategy

The global clinical trials market topped $50 billion last year and, despite the recent downturn in the fortunes of most …
News

US approval boosts Plavix competitor

July 14, 2009 Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
News

Chiesi breaks ground on new R&D headquarters in Palma

July 13, 2009 Research and Development Chiesi, Europe, Italy

Construction of Chiesi's new 70 million euro centre for research and development has begun in Parma, Italy. The Italian company …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026